ERS International Congress, Milan 2017

Browse by day: Saturday, 09.09.2017 Sunday, 10.09.2017 Monday, 11.09.2017 Tuesday, 12.09.2017 Wednesday, 13.09.2017		Sponsored symposia: Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

Lung transplant outcomes

Thematic Poster
Chairs: C. Neurohr (Munich, Germany), C. Pison (Grenoble, France), S. Verleden (Leuven, Belgium), J. Lordan (Newcastle upon Tyne, United Kingdom)

Download all media

Bronchial stenosis treatment after lung transplantation N. Nechaev (Moscow, Russian Federation)
Bronchial anastomotic complication in alpha1-antitrypsin deficiency J. Kleinerova (Dublin 8, Ireland)
Effect of early Switch to Belatacept As Primary Immunosuppressive Regimen Among Calcineurin Inhibitor–Intolerant Lung-Transplant Recipients: A single-center series. O. Brugière (Paris, France)
Arterial stiffness measurement on lung transplanted patients. R. Bocskei (Budapest, Hungary)
Quantitative Functional Respiratory Imaging may predict the mechanism of FEV1 Decline after Lung Transplantation W. Vos (Heist-op-den-Berg, Belgium)
Lung ultrasound for the diagnosis of post-operative complications after lung transplantation J. Rømhild Davidsen (Odense C, Denmark)
Semiology of thoracic ultrasound (US) examination in lung transplant patients out of pulmonary complication. S. Droneau (Rouffiac-Tolosan, France)
Could LDH monitoring after lung transplantation be used as screening tool for post-transplant lymphoproliferative disorder (PTLD)? A. Costa-Pozza (Dublin, Ireland)
Chronic lung allograft disease: prevalence and FEV1 decline in a Brazilian lung transplant cohort. F. Didier Neto (SAO PAULO/SP, Brazil)